IBDEI0RL ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36453,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,36454,0)
 ;;=I50.32^^103^1549^48
 ;;^UTILITY(U,$J,358.3,36454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36454,1,3,0)
 ;;=3^Chr Diastolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,36454,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,36454,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,36455,0)
 ;;=I27.82^^103^1549^49
 ;;^UTILITY(U,$J,358.3,36455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36455,1,3,0)
 ;;=3^Chr Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,36455,1,4,0)
 ;;=4^I27.82
 ;;^UTILITY(U,$J,358.3,36455,2)
 ;;=^338238
 ;;^UTILITY(U,$J,358.3,36456,0)
 ;;=I50.22^^103^1549^50
 ;;^UTILITY(U,$J,358.3,36456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36456,1,3,0)
 ;;=3^Chr Systolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,36456,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,36456,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,36457,0)
 ;;=I42.0^^103^1549^53
 ;;^UTILITY(U,$J,358.3,36457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36457,1,3,0)
 ;;=3^Dilated Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,36457,1,4,0)
 ;;=4^I42.0
 ;;^UTILITY(U,$J,358.3,36457,2)
 ;;=^5007194
 ;;^UTILITY(U,$J,358.3,36458,0)
 ;;=I10.^^103^1549^54
 ;;^UTILITY(U,$J,358.3,36458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36458,1,3,0)
 ;;=3^Essential Hypertension
 ;;^UTILITY(U,$J,358.3,36458,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,36458,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,36459,0)
 ;;=I50.9^^103^1549^55
 ;;^UTILITY(U,$J,358.3,36459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36459,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,36459,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,36459,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,36460,0)
 ;;=I35.1^^103^1549^60
 ;;^UTILITY(U,$J,358.3,36460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36460,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,36460,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,36460,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,36461,0)
 ;;=I35.0^^103^1549^61
 ;;^UTILITY(U,$J,358.3,36461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36461,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,36461,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,36461,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,36462,0)
 ;;=I35.2^^103^1549^62
 ;;^UTILITY(U,$J,358.3,36462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36462,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,36462,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,36462,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,36463,0)
 ;;=I35.9^^103^1549^58
 ;;^UTILITY(U,$J,358.3,36463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36463,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,36463,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,36463,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,36464,0)
 ;;=I21.4^^103^1549^57
 ;;^UTILITY(U,$J,358.3,36464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36464,1,3,0)
 ;;=3^NSTEMI Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,36464,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,36464,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,36465,0)
 ;;=I42.8^^103^1549^46
 ;;^UTILITY(U,$J,358.3,36465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36465,1,3,0)
 ;;=3^Cardiomypathies NEC
 ;;^UTILITY(U,$J,358.3,36465,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,36465,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,36466,0)
 ;;=I20.8^^103^1549^7
 ;;^UTILITY(U,$J,358.3,36466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36466,1,3,0)
 ;;=3^Angina Pectoris NEC
 ;;^UTILITY(U,$J,358.3,36466,1,4,0)
 ;;=4^I20.8
 ;;^UTILITY(U,$J,358.3,36466,2)
 ;;=^5007078
 ;;^UTILITY(U,$J,358.3,36467,0)
 ;;=I42.2^^103^1549^56
 ;;^UTILITY(U,$J,358.3,36467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36467,1,3,0)
 ;;=3^Hypertrophic Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,36467,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,36467,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,36468,0)
 ;;=I35.8^^103^1549^59
 ;;^UTILITY(U,$J,358.3,36468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36468,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,36468,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,36468,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,36469,0)
 ;;=I42.5^^103^1549^65
 ;;^UTILITY(U,$J,358.3,36469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36469,1,3,0)
 ;;=3^Restrictive Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,36469,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,36469,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,36470,0)
 ;;=I05.8^^103^1549^69
 ;;^UTILITY(U,$J,358.3,36470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36470,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,36470,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,36470,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,36471,0)
 ;;=I08.8^^103^1549^70
 ;;^UTILITY(U,$J,358.3,36471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36471,1,3,0)
 ;;=3^Rheumatic Multiple Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,36471,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,36471,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,36472,0)
 ;;=I47.9^^103^1549^63
 ;;^UTILITY(U,$J,358.3,36472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36472,1,3,0)
 ;;=3^Paroxysmal Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,36472,1,4,0)
 ;;=4^I47.9
 ;;^UTILITY(U,$J,358.3,36472,2)
 ;;=^5007224
 ;;^UTILITY(U,$J,358.3,36473,0)
 ;;=I05.1^^103^1549^66
 ;;^UTILITY(U,$J,358.3,36473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36473,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,36473,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,36473,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,36474,0)
 ;;=I05.0^^103^1549^67
 ;;^UTILITY(U,$J,358.3,36474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36474,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,36474,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,36474,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,36475,0)
 ;;=I05.9^^103^1549^68
 ;;^UTILITY(U,$J,358.3,36475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36475,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,36475,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,36475,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,36476,0)
 ;;=I21.3^^103^1549^71
 ;;^UTILITY(U,$J,358.3,36476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36476,1,3,0)
 ;;=3^STEMI Myocardial Infarction,Unspec Site
 ;;^UTILITY(U,$J,358.3,36476,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,36476,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,36477,0)
 ;;=I44.30^^103^1549^43
 ;;^UTILITY(U,$J,358.3,36477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36477,1,3,0)
 ;;=3^Atrioventricular Block,Unspec
 ;;^UTILITY(U,$J,358.3,36477,1,4,0)
 ;;=4^I44.30
 ;;^UTILITY(U,$J,358.3,36477,2)
 ;;=^5007204
 ;;^UTILITY(U,$J,358.3,36478,0)
 ;;=I50.40^^103^1549^51
 ;;^UTILITY(U,$J,358.3,36478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36478,1,3,0)
 ;;=3^Combined Systolic & Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,36478,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,36478,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,36479,0)
 ;;=I50.30^^103^1549^52
 ;;^UTILITY(U,$J,358.3,36479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36479,1,3,0)
 ;;=3^Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,36479,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,36479,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,36480,0)
 ;;=I50.20^^103^1549^72
 ;;^UTILITY(U,$J,358.3,36480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36480,1,3,0)
 ;;=3^Systolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,36480,1,4,0)
 ;;=4^I50.20
 ;;^UTILITY(U,$J,358.3,36480,2)
 ;;=^5007239
 ;;^UTILITY(U,$J,358.3,36481,0)
 ;;=I20.0^^103^1549^73
 ;;^UTILITY(U,$J,358.3,36481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36481,1,3,0)
 ;;=3^Unstable Angina
 ;;^UTILITY(U,$J,358.3,36481,1,4,0)
 ;;=4^I20.0
 ;;^UTILITY(U,$J,358.3,36481,2)
 ;;=^5007076
 ;;^UTILITY(U,$J,358.3,36482,0)
 ;;=M32.12^^103^1549^64
 ;;^UTILITY(U,$J,358.3,36482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36482,1,3,0)
 ;;=3^Pericarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,36482,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,36482,2)
 ;;=^5011755
 ;;^UTILITY(U,$J,358.3,36483,0)
 ;;=E87.8^^103^1550^3
 ;;^UTILITY(U,$J,358.3,36483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36483,1,3,0)
 ;;=3^Electrolyte/Fluid Balance Disorders NEC
 ;;^UTILITY(U,$J,358.3,36483,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,36483,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,36484,0)
 ;;=E11.9^^103^1550^2
 ;;^UTILITY(U,$J,358.3,36484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36484,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,36484,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,36484,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,36485,0)
 ;;=E10.9^^103^1550^1
 ;;^UTILITY(U,$J,358.3,36485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36485,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,36485,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,36485,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,36486,0)
 ;;=Z79.4^^103^1550^4
 ;;^UTILITY(U,$J,358.3,36486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36486,1,3,0)
 ;;=3^Long Term Use of Insulin
 ;;^UTILITY(U,$J,358.3,36486,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,36486,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,36487,0)
 ;;=H60.03^^103^1551^1
 ;;^UTILITY(U,$J,358.3,36487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36487,1,3,0)
 ;;=3^Abscess Bilateral External Ear
 ;;^UTILITY(U,$J,358.3,36487,1,4,0)
 ;;=4^H60.03
 ;;^UTILITY(U,$J,358.3,36487,2)
 ;;=^5006438
 ;;^UTILITY(U,$J,358.3,36488,0)
 ;;=H60.02^^103^1551^2
 ;;^UTILITY(U,$J,358.3,36488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36488,1,3,0)
 ;;=3^Abscess Left External Ear
 ;;^UTILITY(U,$J,358.3,36488,1,4,0)
 ;;=4^H60.02
 ;;^UTILITY(U,$J,358.3,36488,2)
 ;;=^5006437
 ;;^UTILITY(U,$J,358.3,36489,0)
 ;;=H60.01^^103^1551^3
 ;;^UTILITY(U,$J,358.3,36489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36489,1,3,0)
 ;;=3^Abscess Right External Ear
